Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 16;8(1):14-21.
doi: 10.1093/jhps/hnab001. eCollection 2021 Jan.

Peri-operative platelet-rich plasma in arthroscopic femoroacetabular impingement surgery: a randomized controlled trial

Affiliations

Peri-operative platelet-rich plasma in arthroscopic femoroacetabular impingement surgery: a randomized controlled trial

Gen Lin Foo et al. J Hip Preserv Surg. .

Abstract

This study aimed to determine whether the addition of platelet-rich plasma (PRP) during hip arthroscopy improves functional outcomes in femoroacetabular impingement (FAI) surgery. This was a prospective randomized single-blinded trial of arthroscopic hip patients aged between 16 and 50 years with a diagnosis of FAI conducted at a single centre. Patients with any previous hip surgery and significant osteoarthritic changes (Tonnis grade > 2) were excluded. Before surgery, patients were randomly assigned to receive either a PRP injection or a saline placebo. Efficacy was evaluated at 6 months, 1 year and 2 years post-surgery using patient-reported outcomes. The short version International Hip Outcome Tool (iHOT12) was the primary outcome. Recruited patients (n = 113) were aged 36.0 ± 10.5 (mean ± standard deviation) years and 56% male. At baseline, iHOT12 scores of the PRP (mean 43.8 ± 22.4) and placebo groups (mean 45.2 ± 21.5) were similar. At a minimum follow-up of 2 years, both groups had improved iHOT12 scores (PRP: mean 83.6 ± 13.4, control: mean 77.1 ± 23.3), with no significant difference in change between the two groups (P = 0.19). There were no significant group differences for the change in Non-Arthritic Hip and Hip Disability and Osteoarthritis Outcome Score-Shortform scores between the two groups (P = 0.22 and 0.46, respectively). The present study does not support the peri-operative use of PRP in arthroscopic surgery for FAI for mid-term improvement. There were no significant differences in outcome between PRP and placebo groups at 2-year minimum follow-up after surgery.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flow of participants in study.
Fig. 2.
Fig. 2.
Patient-reported outcome measures at pre-operation, 6 months, 1 year, 2 years, 3 years and 4–5 years. A: IHOT-12 score, B: NAH score, C: HOOS-SF score. Numbers above data points indicate the sample size available from the 58 in the PRP group and 48 in the place group. Error bars are 95% confidence intervals.

References

    1. Jo CH, Shin JS, Lee YG. et al.Platelet-rich plasma for arthroscopic repair of large to massive rotator cuff tears: a randomized, single-blind, parallel-group trial. Am J Sports Med 2013; 41: 2240–8. - PubMed
    1. Miller LE, Parrish WR, Roides B. et al.Efficacy of platelet-rich plasma injections for symptomatic tendinopathy: systematic review and metaanalysis of randomised injection-controlled trials. BMJ Open Sport Exerc Med 2017; 3: e000237. - PMC - PubMed
    1. Moraes VY, Lenza M, Tamaoki MJ. et al.Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev 2013; 12: CD010071. - PubMed
    1. Wu Q, Luo X, Xiong Y. et al.Platelet-rich plasma versus hyaluronic acid in knee osteoarthritis: a meta-analysis with the consistent ratio of injection. J Orthopaed Surg 2020; 28: 2309499019887660. - PubMed
    1. Ali M, Oderuth E, Atchia I. et al.The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: a systematic literature review. J Hip Preserv Surg 2018; 5: 209–19. - PMC - PubMed